Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |